Literature DB >> 3752073

Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis.

R Backenroth, B S Spinowitz, M Galler, R A Golden, J H Rascoff, C Charytan.   

Abstract

Eosinophilia (E) has been noted in hemodialysis (HD) patients, but its etiology is not clear. In an effort to clarify this phenomenon, we prospectively studied patients initiating dialysis in our outpatient HD and peritoneal dialysis programs. Rate of E was greatest for a small group of four continuous cycling peritoneal dialysis patients (75%), less for 63 HD patients (41%), and least for 66 continuous ambulatory peritoneal dialysis (CAPD) patients (21%, P less than .05, HD v CAPD). Increasing E rates among the groups paralleled increased frequency of tubing changes. There were no differences in etiology of renal disease, medications, types of dialyzers, types of access, or transfusion frequency that could account for the E. IgE levels did not correlate with E. The data suggest that the dialysis procedure or the tubing changes may be causing the E, but the possibility that uremia, itself, is important in the pathogenesis of dialysis E is also discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3752073     DOI: 10.1016/s0272-6386(86)80023-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  Eosinophil count and mortality risk in incident hemodialysis patients.

Authors:  Duk-Hee Kang; Yuji Lee; Carola Ellen Kleine; Yong Kyu Lee; Christina Park; Jui-Ting Hsiung; Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Nephrol Dial Transplant       Date:  2020-06-01       Impact factor: 5.992

2.  Eosinophilia and risk of incident end stage kidney disease.

Authors:  Anam Tariq; Keisuke Okamato; Azka Tariq; Avi Z Rosenberg; Karim M Soliman; David W Ploth; Mohamed G Atta; Blaithin A McMahon
Journal:  BMC Nephrol       Date:  2020-01-13       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.